Thomas E. Ahlering

Dr. Thomas E. Ahlering is a Professor and Vice Chairman in the Department of Urology at the University of California, Irvine (UCI) School of Medicine. He is a leading expert in urologic oncology, specializing in robotic radical prostatectomy for prostate cancer, with over 2,500 surgeries performed. He previously served as Chief of Urologic Oncology at City of Hope and Chief of Urology at UC Irvine. His clinical and research work has earned him recognition as one of America’s Best Doctors since 1994 and as a Top 2% Medical Scientist globally.

Dr. Ahlering's research interests center on urologic oncology, particularly robotic surgery, functional recovery after prostatectomy, and patient-reported outcomes. He has pioneered techniques in nerve-sparing and urinary anastomosis to improve continence and potency. His work has significantly contributed to the adoption and refinement of da Vinci robotic systems in urologic surgery.

His scholarly output includes over 400 publications, with recent work focusing on surgical innovation, international training, patient selection, and long-term oncological outcomes. The articles reflect a strong emphasis on improving surgical precision, minimizing complications, and enhancing quality of life. Themes include technological evolution, global dissemination of robotic techniques, and patient-centered care.

Scientific recognition includes:

• Lifetime Achievement Award in Robotic Surgery (North American Robotic Urology Symposium)
• Outstanding Faculty Achievement – Lauds and Laurels (UCI Alumni Association)
• Mentor of the Year (UCI Institute of Clinical and Translational Science)
• Top 2% of Medical Scientists in the World (Stanford Study)
• Consistently listed in America’s Best Doctors since 1994

Dr. Ahlering has mentored numerous trainees and residents, contributing significantly to education in urologic oncology. His lab and surgical team, often referred to as "The A-Team," operate at MiVIP Surgical Center and are known for their high coordination, patient-centered approach, and expertise in robotic prostatectomy. He continues to lead innovation in urinary diversion techniques such as the Indiana pouch and ileal neobladder.